第五届单细胞与空间组学论坛近日，中山大学孙逸仙纪念医院研究团队在期刊《Advanced Science》上发表了研究论文，题为“Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated ...

FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...

In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.

ADT with leuprolide was tied to increased coronary plaque vs relugolix in prostate cancer. What does this mean for CV risk?

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Prostate cancer is among the most prevalent cancers in men, particularly above the age of 50. In India, prostate cancer has been increasingly reported, with the urban population being at a higher risk ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

When it comes to detecting cancer, you want the fastest detection possible in order to treat it accurately and in a timely ...